We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.30 | 1.10 | 1.50 | 0.00 | 07:31:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -3.71 | 1.76M |
TIDMPYC
RNS Number : 5908Y
Physiomics PLC
06 December 2017
Physiomics plc
("Physiomics") or ("the Company")
Issue of Equity
Physiomics plc announces today that following the receipt of notice of exercise of employee options, 1,768,815 Ordinary Shares of 0.4p each in the Company (the "Options Shares") have now been issued to the following employees at the following exercise prices:
Grantee Number of shares Exercise price issued per option ------------------- ----------------- --------------- Dr J Millen, CEO 484,641 2.5p ------------------- ----------------- --------------- Dr C Chassagnole, COO 645,231 3.5p ------------------- ----------------- --------------- Dr C Chassagnole, COO 219,880 2.5p ------------------- ----------------- --------------- Other staff 96,448 2.5p ------------------- ----------------- --------------- Other staff 322,615 3.5p ------------------- ----------------- ---------------
Application has been made to admit the Option Shares to trading on AIM, and dealings in the Option Shares are expected to commence on 12th December 2017.
Following the issue of the Option Shares, the total holdings of each Director of the Company will be as follows:
Dr Paul Harper 525,707 Dr Jim Millen 684,641 Dr Christophe Chassagnole 1,017,008
Following the issue of the Option Shares, the total number of shares now in issue is 58,785,394 Ordinary Shares with voting rights attached (one vote per Share). There are no Shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, Physiomics under the Disclosure and Transparency Rules.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person closely associated --- ----------------------------------------------------------------------------------------------- a) Name James Millen --- -------------------------------------------------------------- ------------------------------- 2 Reason for the notification --- ----------------------------------------------------------------------------------------------- a) Position/status Director, CEO --- -------------------------------------------------------------- ------------------------------- b) Initial notification/ Amendment Initial notification --- -------------------------------------------------------------- ------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ----------------------------------------------------------------------------------------------- a) Name Physiomics plc --- -------------------------------------------------------------- ------------------------------- b) LEI 213800A71DSZ6ABMTQ91 --- -------------------------------------------------------------- ------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ----------------------------------------------------------------------------------------------- a) Description of the financial instrument, type of instrument Ordinary share Identification code GB00BDR6W943 --- -------------------------------------------------------------- ------------------------------- b) Nature of the transaction Share Incentive Plan purchase --- -------------------------------------------------------------- ------------------------------- c) Price(s) and volume(s) Price(s) Volume(s) --------- ---------- 2.5p 484,641 --------- ---------- --- -------------------------------------------------------------- ------------------------------- d) Aggregated information * Aggregated volume 484,641 At 2.5p per share * Price --- -------------------------------------------------------------- ------------------------------- e) Date of the transaction 6-12-2017 --- -------------------------------------------------------------- ------------------------------- f) Place of the transaction XLON, AIM --- -------------------------------------------------------------- -------------------------------
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person closely associated --- --------------------------------------------------------------------------------------------------------- a) Name Christophe Chassagnole --- ------------------------------------------------------------ ------------------------------------------- 2 Reason for the notification --- --------------------------------------------------------------------------------------------------------- a) Position/status Director, COO --- ------------------------------------------------------------ ------------------------------------------- b) Initial notification/ Amendment Initial notification --- ------------------------------------------------------------ ------------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- --------------------------------------------------------------------------------------------------------- a) Name Physiomics plc --- ------------------------------------------------------------ ------------------------------------------- b) LEI 213800A71DSZ6ABMTQ91 --- ------------------------------------------------------------ ------------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- --------------------------------------------------------------------------------------------------------- a) Description of the financial instrument, type of instrument Ordinary share Identification code GB00BDR6W943 --- ------------------------------------------------------------ ------------------------------------------- b) Nature of the transaction Share Incentive Plan purchase --- ------------------------------------------------------------ ------------------------------------------- c) Price(s) and volume(s) Price(s) Volume(s) --------- ---------- 3.5p 645,231 --------- ---------- 2.5p 219,880 --------- ---------- --- ------------------------------------------------------------ ------------------------------------------- d) Aggregated information * Aggregated volume 865,111 At 2.5p and 3.5p as shown in table above * Price --- ------------------------------------------------------------ ------------------------------------------- e) Date of the transaction 6-12-2017 --- ------------------------------------------------------------ ------------------------------------------- f) Place of the transaction XLON, AIM --- ------------------------------------------------------------ -------------------------------------------
Enquiries:
Physiomics plc
Dr Jim Millen, CEO
+44 (0)1865 784 980
WH Ireland Limited (nomad)
Katy Mitchell, James Sinclair-Ford
+44 (0) 161 832 2174
Hybridan LLP (broker)
Claire Louise Noyce
+44 (0) 203 764 2341
The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.
IOEEALAKEANXFFF
(END) Dow Jones Newswires
December 06, 2017 10:00 ET (15:00 GMT)
1 Year Physiomics Chart |
1 Month Physiomics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions